|
Dr. Minna is Director of the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and the W.A. Tex and Deborah Moncrief, Jr. Center for Cancer Genetics at The University of Texas Southwestern Medical Center at Dallas. He holds the Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology and the Sarah M. and Charles E. Seay Distinguished Chair in Cancer Research. He received his undergraduate and medical degrees from Stanford University and was an intern and resident in medicine at Massachusetts General Hospital. He then went to the National Institutes of Health (NIH) as a Research Associate with Dr. Marshal Nirenberg and became first Chief of the Section of Somatic Cell Genetics, and then Chief of first the NCI-VA and then NCI-Navy Medical Oncology Branches at the National Cancer Institute (NCI). Later he joined the faculty at UT Southwestern Medical Center.
Dr. Minna’s work has focused on understanding the molecular pathogenesis of lung cancer and translating this into the clinic. He has led a joint Lung Cancer NCI Special Program of Research Excellence (SPORE) grant between UTSW and the MD Anderson Cancer Center and is currently discovering the molecular signatures in lung cancer predictive of response to therapy as well as how to target this therapy. He has also authored and co-authored significant publications, including the Harrison’s Textbook of Medicine Chapter on Lung Cancer, and Focus on Lung Cancer; Tumor Suppressor Genes on Chromosome 3p Involved in the Pathogenesis of Lung and Other Cancers; Molecular Pathogenesis of Lung Cancer and Potential Translational Applications and has authored or co-authored over 500 publications, review articles and editorials. He has served on the Scientific Advisory Board for the National Cancer Institute (NCI), as well as on the Board of Directors for AACR and ASCO. | 